ArticleInternational journal of biomaterials2026
Antiviral Surface Protection of Polyhedral Oligomeric Silsesquioxanes (POSS)-Appended Hybrid Surface Materials.
Article in International journal of biomaterials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Antiviral Surface Protection of Polyhedral Oligomeric Silsesquioxanes (POSS)-Appended Hybrid Surface Materials.International journal of biomaterials · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Rapid technological advancement has led to a growing need for new materials with enhanced properties to meet the demands of emerging applications. Traditional single-component materials often fail to meet the required demands, pushing the exploration of new composite materials. In these contexts, polyhedral oligomeric silsesquioxanes (POSS) as hybrid nanomaterials exhibit excellent mechanical, thermal and chemical stability, making them ideal for advanced material design. In addition, their hydrophobic nature and ability to be functionalized enable antimicrobial properties with enhanced resistance to microbial adhesion. Compared to hybrid nanomaterials, single-component antiviral materials have limitations, including short-term durability and low surface stability. The rationale for developing the POSS-stearic acid hybrid composite is based on the ability to form a rigid nanocage framework of POSS, which provides structural robustness and enhanced stability. We show that by combining POSS with stearic acid, the hybrid material displays greater hydrophobicity than its individual components, making it an effective surface coating material that prevents the attachment of microbial pathogens, including viruses, such as human coronavirus-OC43 (HCoV-OC43) and Type A influenza virus (H1N1). We provide evidence that the present material not only serves as a barrier to viral attachment to the surface but also significantly reduces viral infectivity, possibly through direct neutralization, thereby offering a promising strategy for mitigating surface-mediated transmission of respiratory viruses.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.